{"SPADE_N_14057": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14057", "Peptide Name": "PMAP-37(R13-I) (PMAP-37 R13I, synthetic AMPs, UCLL1)", "Source": "Amino acid substitution, cathelicidin analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "GLLSRLRDFLSDIGRRLGEKIERIGQKIKDLSEFFQS", "Sequence Length": 37, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 4321.94, "PI": 9.69, "Hydrophobicity": -0.48, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Zhou J, Liu Y, Shen T, Chen L, Zhang C, Cai K, Liu Z, Meng X, Zhang L, Liao C, Wang C.2019", "Reference": "Chem Biol Drug Des. 2019 Sep;94(5):1986-1999. doi: 10.1111/cbdd.13601.PubMed", "Title": "Enhancing the antibacterial activity of PMAP-37 by increasing its hydrophobicity."}], "Frequent Amino Acids": "LRG", "Absent Amino Acids": "ACHMNOPTUVWY", "Basic Residues": 8, "Acidic Residues": 6, "Hydrophobic Residues": 13, "Polar Residues": 14, "Positive Residues": 8, "Negative Residues": 6, "Net Charge": 2, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (97.3%) toPMAP-37Activity: Active against Gram+ S. aureus ATCC25923 (MIC 0.049 ug/ml), S. epidermidis LY8 (MIC 25 ug/ml), L.monocytogenes CICC21533 (MIC 125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), Gram- S. choleraesuis C78-1 (MIC 0.78 ug/ml), S. typhimurium SL1344 (MIC 1.56 ug/ml), P. avium C48-3 (MIC 3.125 ug/ml), E. coli CICC10004 (MIC 25 ug/ml), and S. flexneri CICC21534 (MIC 75 ug/ml).Toxicity: 3% hemolysis till 1000 ug/ml (poor hemo.lytic). Little toxicity to NIH 3T3 till 1000 ug/ml.Animal model:mouse: more animal survived with the peptide treatment for 3 days.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_21526", "Similarity": 1.0, "Sequence": "GLLSRLRDFLSDIGRRLGEKIERIGQKIKDLSEFFQS"}, {"SPADE_ID": "SPADE_N_02562", "Similarity": 0.972972972972973, "Sequence": "GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS"}, {"SPADE_ID": "SPADE_N_14054", "Similarity": 0.9459459459459459, "Sequence": "GLLSRLRDRLSDRGRRLGEKIERIGQKIKDLSEFFQS"}]}}}